In order to further demonstrate the functions of PSMA in the development of glioma, orthotopic xenograft models were constructed through the intracranial injection of U87-luc cells and divided into Ctrl group and 2-PMPA group, mice in which were treated by 2-PMPA for 2 weeks after the formation of xenografts. This evidence concerns the gene FOLH1 and central nervous system cancer.